PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Lorecivivint, page-25

  1. 326 Posts.
    lightbulb Created with Sketch. 37
    Very interesting results. seems to take some time to get actual relief
    irrespective it will be hard to compete with a US based company
    Someone with more of a scientific background could compare better than I
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.